Table 3 Analysis of maximum likelihood estimates
From: Serum erythropoietin levels, breast cancer and breast cancer-initiating cells
Parameter |  | DF | Estimate | Standard error | Wald chi-square | Pr > ChiSq |
|---|---|---|---|---|---|---|
Intercept | Â | 1 | 15.1728 | 25.4962 | 0.3541 | 0.5518 |
Epo (mIU/mL) |  | 1 | − 0.1674 | 0.0664 | 6.3653 | 0.0116 |
Age |  | 1 | − 0.0352 | 0.0331 | 1.1282 | 0.2881 |
Numeric stage | 0 | 1 | − 20.4155 | 224.3 | 0.0083 | 0.9275 |
Numeric stage | 1 | 1 | 5.6702 | 74.7554 | 0.0058 | 0.9395 |
Numeric stage | 2 | 1 | 5.8172 | 74.7587 | 0.0061 | 0.9380 |
Hgb |  | 1 | − 0.5733 | 0.3153 | 3.3058 | 0.0690 |
Triple negative | 0 | 1 | 5.2131 | 33.6736 | 0.0240 | 0.8770 |
Chemotherapy | 0 | 1 | 1.0505 | 0.7933 | 1.7536 | 0.1854 |
Receptor status | 0 | 1 | 5.6305 | 33.6720 | 0.0280 | 0.8672 |
Histology | DCIS | 1 | 19.3640 | 199.3 | 0.0094 | 0.9226 |
Histology | IDC | 1 | − 9.4229 | 99.6720 | 0.0089 | 0.9247 |